Susquehanna Portfolio Strategies, LLC Kodiak Sciences Inc. Transaction History

Susquehanna Portfolio Strategies, LLC

  • $29.7 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$2.2 - $3.25 $170,594 - $252,014
-77,543 Reduced 88.1%
10,473 $27.3 Million
Q2 2024

Aug 15, 2024
SELL
$2.29 - $4.48 $32,868 - $64,301
-14,353 Reduced 14.02%
88,016 $207 Million
Q4 2023

Feb 14, 2024
BUY
$1.4 - $3.24 $143,316 - $331,675
102,369 New
102,369 $311 Million

Others Institutions Holding KOD

# of Institutions
109
Shares Held
40.9M
Call Options Held
28.4K
Put Options Held
21.2K
View Full List

About Kodiak Sciences Inc.

KOD Quotes by TradingView
  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $232M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Susquehanna Portfolio Strategies, LLC Portfolio

Follow Susquehanna Portfolio Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Portfolio Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Portfolio Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email